Comment
doi: 10.7326/ACPJ202106150-064.
Epub 2021 Jun 1.
In patients hospitalized with COVID-19, adding azithromycin to usual care did not reduce 28-d mortality
Affiliations
- PMID: 34058103
- DOI: 10.7326/ACPJ202106150-064
Item in Clipboard
Comment
In patients hospitalized with COVID-19, adding azithromycin to usual care did not reduce 28-d mortality
Ann Intern Med.
2021 Jun.
Abstract
RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:605-12. 33545096.
Comment on
-
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.Lancet. 2021 Feb 13;397(10274):605-612. doi: 10.1016/S0140-6736(21)00149-5. Epub 2021 Feb 2. Lancet. 2021. PMID: 33545096 Free PMC article. Clinical Trial.
Similar articles
-
In patients hospitalized with COVID-19, adding convalescent plasma to usual care did not reduce 28-d mortality.Ann Intern Med. 2021 Oct;174(10):JC113. doi: 10.7326/ACPJ202110190-113. Epub 2021 Oct 5. Ann Intern Med. 2021. PMID: 34606320
-
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9. Trials. 2020. PMID: 32522282 Free PMC article.
-
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.Lancet. 2020 Oct 3;396(10256):959-967. doi: 10.1016/S0140-6736(20)31862-6. Epub 2020 Sep 5. Lancet. 2020. PMID: 32896292 Free PMC article. Clinical Trial.
-
Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis.J Nepal Health Res Counc. 2021 Apr 23;19(1):1-9. doi: 10.33314/jnhrc.v19i1.3270. J Nepal Health Res Counc. 2021. PMID: 33934125
-
Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection.Eur J Pharmacol. 2021 Aug 15;905:174191. doi: 10.1016/j.ejphar.2021.174191. Epub 2021 May 17. Eur J Pharmacol. 2021. PMID: 34015317 Free PMC article. Review.
Cited by
-
The Impact of Early Antibiotic Use on Clinical Outcomes of Patients Hospitalized with COVID-19: A Propensity Score-Matched Analysis.Infect Drug Resist. 2024 Aug 9;17:3425-3438. doi: 10.2147/IDR.S470957. eCollection 2024. Infect Drug Resist. 2024. PMID: 39145118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
